BIOTRICITY INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+10.2% +$369K
$4M
Cost of Revenue↓-13.9% -$119K
$736K
Gross Profit↑+17.6% +$488K
$3M
R&D↑+13.1% +$72K
$624K
SG&A↓-8.2% -$195K
$2M
D&A↓-0.1% -$1
$1K
Operating Income↑+360.9% +$610K
$441K
EBITDA↑+364.1% +$610K
$442K
Interest Expense↓-4.6% -$39K
$810K
Other Income/Expense↓-65.0% -$137K
$-348K
Pretax Income↑+41.7% +$512K
$-717K
Tax Provision
—
Net Income↑+41.7% +$512K
$-717K
Gross Margin↑+5.2pts
81.5%
Operating Margin↑+15.7pts
11.1%
Net Margin↑+16.0pts
-18.0%
Deferred Tax Assets
—
NOL Carryforwards
—
ETR Federal Statutory
26.0%
ETR State + Local (pp)
—
Operating Lease Cost
—
Revenue YoY Variation↓-11.5pts
10.2%
Income YoY Variation↑+274.1pts
360.9%
Revenue QoQ Variation↓-8.2pts
2.6%
Income QoQ Variation↑+15.9pts
61.0%